HarmonyBridge will be led by an experienced executive team spanning healthcare leadership, paediatric clinical expertise, operations and finance, governed by a board with strong clinical, commercial and independent representation. The leadership and shareholding below represent the proposed structure for the enterprise being established, to be finalised on funding; investor- and DFI-nominated directors will join the board as the capital structure introduces external stakeholders.
|
Role |
Mandate |
Profile sought |
|---|---|---|
|
Chief Executive Officer |
Strategy, capital, growth & stakeholders |
Senior healthcare-enterprise leadership |
|
Chief Medical Officer |
Clinical model, quality, outcomes & governance |
Senior paediatric / rehabilitation clinician |
|
Chief Operating Officer |
Multi-site operations, rollout & workforce |
Hospital / network operations leadership |
|
Chief Financial Officer |
Funding, controls & payer contracting |
Healthcare corporate finance |
|
Independent Non-Exec Chair |
Board leadership & governance |
Independent healthcare / finance |
Governance architecture
- A board combining executive leadership with independent non-executive and investor- and DFI-nominated directors, chaired independently.
- A Clinical Governance & Quality committee, central in paediatric care, alongside Audit & Risk and Remuneration committees, with monthly management accounts and quarterly investor reporting.
- Rigorous clinical governance: medical leadership, quality and patient-safety systems, infection control, outcomes measurement and regulatory compliance (OHSC, SAHPRA, Council for Medical Schemes).
- A delegation-of-authority framework governing capital commitments, new-centre approvals, payer contracts, clinical protocols and related-party transactions.
Clinical governance and workforce as strategic priorities
As a paediatric clinical enterprise, HarmonyBridge’s governance and workforce are inseparable from its strategy. Clinical governance and outcomes measurement are not compliance overheads but the foundation of payer contracting, referral confidence and the brand. And because specialist clinical staff are scarce, workforce planning, recruitment, training, remuneration and retention, supported by the training academy, is a board-level priority and a core determinant of the rollout pace. The plan institutionalises clinical standards, outcomes measurement and workforce development as central governance functions from the outset.